Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00147056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors

StatusActive, Not Recruiting
PhaseNot applicable
SponsorInSightec
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2022 to Dec 2026v27
  2. Re-verified, no change to tracked fieldsv26
  3. Trial status: Recruiting to Active, Not Recruiting Site details revised at 2 of 2 sitesv25 Show 1 more changeShow less
    • Site details revised at 2 of 2 sites
  4. Re-verified, no change to tracked fieldsv24
  5. Primary and study completion dates: Dec 2018 to Dec 2022v23
Show 21 earlier versionsHide 21 earlier versions
  1. Phase: Phase 1 to Not applicable Primary and study completion dates: Dec 2017 to Dec 2018v22 Show 1 more changeShow less
    • Primary and study completion dates: Dec 2017 to Dec 2018
  2. Primary and study completion dates: Dec 2016 to Dec 2017v21
  3. Site details revised at 1 of 2 sitesv20
  4. Primary and study completion dates: Dec 2015 to Dec 2016 Site contacts updated at 1 of 2 sitesv19 Show 1 more changeShow less
    • Site contacts updated at 1 of 2 sites
  5. Eligibility criteria expanded, about 76 wordsv18 See this version in full on ClinicalTrials.gov ↗
  6. Primary and study completion dates: Dec 2014 to Dec 2015v17
  7. Study sites: 1 to 2v16
  8. Study sites: 2 to 1 Primary completion date: Jul 2014 to Dec 2014 · Completion date: Aug 2014 to Dec 2014v15 Show 2 more changesShow less
    • Primary completion date: Jul 2014 to Dec 2014
    • Completion date: Aug 2014 to Dec 2014
  9. Site contacts updated at 1 of 2 sitesv14
  10. Primary endpoint revised Interventions: ExAblate 4000 (Device) to ExAblate transcranial system (Device) · Eligibility criteria shortened, about 250 words · Study description shortened, about 9 wordsv13 Show 3 more changesShow less
    • Interventions: ExAblate 4000 (Device) to ExAblate transcranial system (Device)
    • Eligibility criteria shortened, about 250 words
    • Study description shortened, about 9 words

    See this version in full on ClinicalTrials.gov ↗

  11. Primary endpoint revised Eligibility criteria expanded, about 94 wordsv12 Show 1 more changeShow less
    • Eligibility criteria expanded, about 94 words

    See this version in full on ClinicalTrials.gov ↗

  12. Study sites: 1 to 2v11
  13. Trial status: Not Yet Recruiting to Recruiting Interventions: ExAblate 3000 (Device) to ExAblate 4000 (Device) · Site details revised · Study arms: 0 to 1v10 Show 3 more changesShow less
    • Interventions: ExAblate 3000 (Device) to ExAblate 4000 (Device)
    • Site details revised
    • Study arms: 0 to 1
  14. Primary completion date: Jul 2013 to Jul 2014 Completion date: Aug 2013 to Aug 2014 · Study site revisedv9 Show 2 more changesShow less
    • Completion date: Aug 2013 to Aug 2014
    • Study site revised

    See this version in full on ClinicalTrials.gov ↗

  15. Start date: Aug 2006 to Aug 2012 Trial status: Recruiting to Not Yet Recruitingv8 Show 1 more changeShow less
    • Trial status: Recruiting to Not Yet Recruiting
  16. Trial status: Active, Not Recruiting to Recruiting Primary completion date: Jul 2009 to Jul 2013 · Completion date: Aug 2009 to Aug 2013 · Site details revisedv7 Show 3 more changesShow less
    • Primary completion date: Jul 2009 to Jul 2013
    • Completion date: Aug 2009 to Aug 2013
    • Site details revised
  17. Re-verified, no change to tracked fieldsv6
  18. Trial status: Recruiting to Active, Not Recruiting Primary completion date: Jul 2009 · Completion date: Aug 2009 · Site details revisedv5 Show 3 more changesShow less
    • Primary completion date: Jul 2009
    • Completion date: Aug 2009
    • Site details revised
  19. Trial status: Not Yet Recruiting to Recruiting Site details revisedv4 Show 1 more changeShow less
    • Site details revised
  20. Start date: May 2006 to Aug 2006v3
  21. Trial status: Recruiting to Not Yet Recruiting Start date: May 2006 · Site details revised · Study title shortened, about 1 wordv2 Show 3 more changesShow less
    • Start date: May 2006
    • Site details revised
    • Study title shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
InSightec
42 trials monitored
See 1 trial at risk
The purpose of this study is to evaluate the safety of MRI-guided focused ultrasound thermal ablation of brain tumors performed through intact human skull using the ExAblate transcranial system. We will collect data to establish the basic safety of this type of treatment as the basis for later studies that will evaluate its clinical efficacy.
Trial Details
NCT Number NCT00147056
Lead Sponsor InSightec
Conditions Brain Tumor
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov